ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Gene Therapy

Lonza opens cell and gene therapy facility

by Ryan Cross
April 15, 2018 | APPEARED IN VOLUME 96, ISSUE 16

09616-buscon15-lonzacxd.jpg
Credit: Lonza
Lonza says its new facility is the largest of its kind in the world.

Lonza has opened a 28,000-m2 facility for cell and gene therapy manufacturing in Pearland, Texas, south of Houston. Cell and gene therapies often use viruses to shuttle DNA into cells, with some therapies requiring trillions of viruses in a single treatment. The field is undergoing significant growth, buoyed by the U.S. FDA’s approval of the first cell and gene therapies last year. That growth has stymied supplies of the viruses needed to make the therapies. Lonza’s new facility, which it claims is the largest of its kind, will help close the gap.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment